Search for: "Takeda California"
Results 61 - 73
of 73
Sorted by Relevance
|
Sort by Date
27 Sep 2009, 5:13 pm
Takeda Chemical Industries, Ltd., et al. [read post]
3 Sep 2014, 9:00 am
Takeda Pharmaceutical Company Limited 13-1236Issue: Whether the “freely given” standard for the amendment of pleading embodied in Federal Rule of Civil Procedure 15(a), and espoused in Foman v. [read post]
6 Mar 2014, 12:41 pm
Then there are New York ("subject to and complies with"), Washington ("permitted, prohibited or regulated") and California (a common-law carve out for "business practices which the Legislature has expressly declared to be lawful in other legislation," see Cel-Tech Communications, Inc. v. [read post]
9 Dec 2009, 3:59 pm
(Patent Docs) Rozerem (Ramelteon) – US: Complaint filed in Delaware: Infringement of US patent following a Paragraph IV challenge: Takeda Pharmaceutical Co. [read post]
27 Mar 2009, 8:00 am
; no skulduggery involved in pharma enquiry submission switch says EPO (IPKat) (IAM) India: Public sector IP and socially responsible licensing (Spicy IP) India: Pharma lobby wants a probe into delayed orders (Spicy IP) UK: Euro costs in UK litigation: Actavis UK Ltd v Novartis AG (PatLit) US: Two biosimilars bills introduced in the House: HR 1427, the Promoting Innovation and Access to Life Saving Medicine Act; and H.R. 1548, the Pathway to BioSimilars Act (California Biotech Law Blog)… [read post]
27 Jan 2012, 7:13 am
As a result, the FDA ordered the drug’s manufacturer, Takeda Pharmaceuticals North America, Inc., to update Actos symptoms on the drug’s label earlier this fall. [read post]
28 Dec 2012, 1:57 pm
We hope all our readers had an excellent holiday-of-your-choice. [read post]
30 Dec 2013, 5:25 am
Takeda Pharmaceutical Co. [read post]
31 Dec 2014, 5:00 am
All these actions – many hundreds of plaintiffs – were filed in various California state trial courts. [read post]
28 Apr 2008, 11:00 am
: (Patent Docs), US: Supreme Court declines to hear final Nucleonics’ appeal in gene-silencing patent dispute with Benitec Australia: (IP Law360), (Therapeutics Daily), US: 505(b)(2) drug approvals rock - Interaction of patents and exclusivity of drugs approved by FDA under section 505(b)(2): (Patent Baristas), US: StemCells’ patents survive reexam – StemCells and Neuralstem differ on extent of changes: (Patent Docs), US: StemCells announces issuance of… [read post]
11 Apr 2008, 9:00 am
’ – 18 – 22 June, US/Alaska: (Public Knowledge), Center for IP 8th Annual IP Symposium – 28-30 May, Maryland US: (Public Knowledge), University of Maastricht: Conference on public health, innovation and intellectual property – 15 April, Maastricht (Netherlands): (IPR-Helpdesk), NLSIU Symposium: ‘Challenges to India’s patent regime’ – 12-13 April: (Spicy IP), Anti-counterfeiting and brand… [read post]
3 May 2014, 8:56 am
After a long winter, the cherry trees are finally managing to blossom. [read post]
13 Jun 2008, 3:40 am
’ – London: (IPKat), 18 June: CC technology summit – California: (creativecommons.org), 18-20 June: IIR generic drugs summit – Washington: (Orange Book Blog), 18-20 June / 9-11 July: US PLI: ‘Fundamentals of patent prosecution 2008: A boot camp for claim drafting & amendment writing’ – New York / San Francisco: (Patent Docs), 19-20 June: 27th ECTA Conference ‘Forty shades of green: a tour of the IP… [read post]
